TECHNICAL COMMUNICATIONS CORP

2023 Q3 Form 10-Q Financial Statement

#000117184323005067 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.25K $36.86K
YoY Change 22.76% -83.31%
Cash & Equivalents $45.25K $36.86K
Short-Term Investments
Other Short-Term Assets $233.1K $194.3K
YoY Change 20.01% 13.99%
Inventory $1.241M $1.093M
Prepaid Expenses
Receivables $13.83K $22.23K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.533M $1.347M
YoY Change 13.83% -27.56%
LONG-TERM ASSETS
Property, Plant & Equipment $7.560K $289.4K
YoY Change -97.39% 4694.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $133.5K $289.4K
YoY Change -53.86% -35.86%
TOTAL ASSETS
Total Short-Term Assets $1.533M $1.347M
Total Long-Term Assets $133.5K $289.4K
Total Assets $1.667M $1.636M
YoY Change 1.86% -29.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $597.7K $146.0K
YoY Change 309.32% 30.05%
Accrued Expenses $602.7K $360.2K
YoY Change 67.31% -1.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.350M
YoY Change -100.0% 421.06%
Long-Term Debt Due $946.3K $2.760K
YoY Change 34187.32%
Total Short-Term Liabilities $2.309M $2.958M
YoY Change -21.96% 81.67%
LONG-TERM LIABILITIES
Long-Term Debt $3.204M $147.2K
YoY Change 2075.82% -1.84%
Other Long-Term Liabilities $0.00 $126.0K
YoY Change -100.0% -56.34%
Total Long-Term Liabilities $3.204M $273.2K
YoY Change 1072.56% -37.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.309M $2.958M
Total Long-Term Liabilities $3.204M $273.2K
Total Liabilities $5.513M $3.232M
YoY Change 70.58% 56.35%
SHAREHOLDERS EQUITY
Retained Earnings -$8.429M
YoY Change
Common Stock $4.583M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.846M -$1.595M
YoY Change
Total Liabilities & Shareholders Equity $1.667M $1.636M
YoY Change 1.86% -29.18%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-34816
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Domino Drive
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2295040
dei Entity Address City Or Town
EntityAddressCityOrTown
Concord
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01742-2892
dei City Area Code
CityAreaCode
978
dei Local Phone Number
LocalPhoneNumber
287-5100
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1240889 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125975 usd
CY2023Q2 us-gaap Assets
Assets
1666638 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1854403
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1854403
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1854403
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1854403
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Central Index Key
EntityCentralIndexKey
0000096699
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-24
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
tcco Number Of Countries In Which Products Are Sold
NumberOfCountriesInWhichProductsAreSold
2 pure
CY2022Q2 tcco Number Of Countries In Which Products Are Sold
NumberOfCountriesInWhichProductsAreSold
1 pure
tcco Number Of Countries In Which Products Are Sold
NumberOfCountriesInWhichProductsAreSold
2 pure
CY2023Q2 tcco Number Of Countries In Which Products Are Sold
NumberOfCountriesInWhichProductsAreSold
1 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-06-24
dei Entity Registrant Name
EntityRegistrantName
TECHNICAL COMMUNICATIONS CORPORATION
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1854403
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45247 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6727 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13829 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15174 usd
CY2022Q3 us-gaap Grants Receivable Current
GrantsReceivableCurrent
515966 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
966185 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
233138 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
186963 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1533103 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1691015 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4556143 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4556144 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4548583 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4544778 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7560 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11366 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
248462 usd
CY2022Q3 us-gaap Assets
Assets
1950843 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125975 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
164086 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
597684 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
159388 usd
CY2023Q2 tcco Customer Deposit Current
CustomerDepositCurrent
154233 usd
CY2022Q3 tcco Customer Deposit Current
CustomerDepositCurrent
3933 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
166650 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
204412 usd
CY2023Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
310051 usd
CY2022Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
118208 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7987 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1419 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2308905 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3653442 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84376 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5512580 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3885822 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1854403
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1854403
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1854403
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1854403
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
185440 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
185440 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4397343 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4364687 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8428725 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6485106 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3845942 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1934979 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1666638 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1950843 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34972 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146089 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
63658 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
182511 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-28686 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-36422 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
268760 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
450723 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106135 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
318643 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
374895 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
769366 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-403581 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-805788 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3010 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
65421 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
36563 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-62411 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36563 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-465992 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-842351 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1854403
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1854403
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1854403
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1854403
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
184293 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1134682 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
325039 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1029763 usd
us-gaap Gross Profit
GrossProfit
-140746 usd
us-gaap Gross Profit
GrossProfit
104919 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1074416 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1497732 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
545923 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
503531 usd
us-gaap Operating Expenses
OperatingExpenses
1620339 usd
us-gaap Operating Expenses
OperatingExpenses
2001263 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1761085 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1896344 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
14226 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
us-gaap Interest Expense
InterestExpense
196760 usd
us-gaap Interest Expense
InterestExpense
81651 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-182534 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81651 usd
us-gaap Net Income Loss
NetIncomeLoss
-1943619 usd
us-gaap Net Income Loss
NetIncomeLoss
-1977995 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Net Income Loss
NetIncomeLoss
-1943619 usd
us-gaap Net Income Loss
NetIncomeLoss
-1977995 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3806 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3552 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32656 usd
us-gaap Share Based Compensation
ShareBasedCompensation
38087 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1345 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-258575 usd
tcco Increase Decrease In Government Grant Receivable
IncreaseDecreaseInGovernmentGrantReceivable
-515966 usd
tcco Increase Decrease In Government Grant Receivable
IncreaseDecreaseInGovernmentGrantReceivable
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
274704 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-63907 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
46175 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
24791 usd
tcco Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
150300 usd
tcco Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
-12124 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
598945 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39623 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
961480 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1611166 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1350000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1350000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38520 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-261166 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6727 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
298022 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45247 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36856 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
912 usd
us-gaap Interest Paid Net
InterestPaidNet
4917 usd
us-gaap Interest Paid Net
InterestPaidNet
30433 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3845942 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1595466 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3845942 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1595466 usd
us-gaap Net Income Loss
NetIncomeLoss
-1943619 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2331000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1088000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8428725 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7243 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32656 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13286 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38087 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
48000 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
56700
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
108200
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
164900
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.45
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
-0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
-0
CY2022Q4 tcco Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Forfeitures And Expirations
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableForfeituresAndExpirations
-0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-0
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
56700
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
108200
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
164900
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.45
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2100
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2100
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
8000
CY2023Q1 tcco Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Forfeitures And Expirations
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableForfeituresAndExpirations
7000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
46600
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
103300
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
149900
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.48
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
16500
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
16500
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
-0
CY2023Q2 tcco Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Forfeitures And Expirations
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableForfeituresAndExpirations
-0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
30100
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
119800
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
149900
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.48
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
149900
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.48
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
119800
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.81
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34972 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
184293 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146089 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1134682 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
854080 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
489854 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
386809 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
476331 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1240889 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
966185 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
127952 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
127952 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
85301 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
42651 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
127952 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1977 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
125975 usd
tcco Proceeds From Employee Retention Credits
ProceedsFromEmployeeRetentionCredits
515966 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34972 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
184293 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146089 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1134682 usd

Files In Submission

Name View Source Status
0001171843-23-005067-index-headers.html Edgar Link pending
0001171843-23-005067-index.html Edgar Link pending
0001171843-23-005067.txt Edgar Link pending
0001171843-23-005067-xbrl.zip Edgar Link pending
ex_553183.htm Edgar Link pending
ex_553184.htm Edgar Link pending
ex_553185.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcco-20230624.xsd Edgar Link pending
tcco20230622_10q.htm Edgar Link pending
tcco-20230624_lab.xml Edgar Link unprocessable
tcco-20230624_pre.xml Edgar Link unprocessable
tcco20230622_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tcco-20230624_def.xml Edgar Link unprocessable
tcco-20230624_cal.xml Edgar Link unprocessable